Utah’s business landscape is rich with professionals who have le...Read More
Social Media and Employers: Friends or Enemies?
The Case for HSAs
Time to Show Up
Make a Move
In the Lab
Rent to Own
Back from the Dead
A Breath of Fresh Air
Travel & Tourism
Salt Lake City – Nexus CMF announced at the American Association of Oral and Maxillofacial Surgeons Annual Meeting that it has entered into an agreement with Mayo Clinic to develop new technology for a partial temporomandibular joint (TMJ) prosthesis.
The patented hemiarthroplasty approach is for a non-anatomical patient-specific implant that sits flat on the bone to create more freedom of movement for the patient's jaw joint. This design entails surgical reshaping of the bone and is for patients with osteoarthritis where the interpositional disc is displaced or perforated resulting in bone-on-bone contact.
Nexus CMF will seek to develop this hemiarthroplasty surgical approach, which has undergone a 60-patient study at Mayo prior to its licensing, using its Patient-Specific TMJ Fossa-Eminence Prosthesis System.
Currently the only medical device company with FDA approval to produce partial TMJ prostheses, Nexus CMF is also the only company in the United States to manufacture both stock and patient-specific TMJ prostheses.
“We are thrilled to be able to offer a wide variety of viable prosthesis options that cater to different patient needs and surgical philosophies,” said Andrew Olson, director of sales and marketing at Nexus CMF.